 | | 1PS | | Name: | 3-PYRIDINIUM-1-YLPROPANE-1-SULFONATE | | Formula: | C8 H11 N O3 S | | SMILES: | [O-]S(=O)(=O)CCC[n+]1ccccc1 | | InChi: | InChI=1S/C8H11NO3S/c10-13(11,12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2 | | Synonyms: | 1-(3-SULFOPROPYL) PYRIDINIUM | | Definition date: | 2003-11-14 | | Last modified: | 2020-05-26 | | Identifier: | 3-pyridinium-1-ylpropane-1-sulfonate |
|
 | | 1SY | | Name: | cGAMP | | Formula: | C20 H24 N10 O13 P2 | | SMILES: | O=C7N=C(N)Nc1c7ncn1C5OC6COP(=O)(O)OC4C(OC(n2c3ncnc(N)c3nc2)C4O)COP(=O)(OC5C6O)O | | InChi: | InChI=1S/C20H24N10O13P2/c21-14-8-15(24-3-23-14)29(4-25-8)18-11(32)12-7(41-18)2-39-45(36,37)43-13-10(31)6(1-38-44(34,35)42-12)40-19(13)30-5-26-9-16(30)27-20(22)28-17(9)33/h3-7,10-13,18-19,31-32H,1-2H2,(H,34,35)(H,36,37)(H2,21,23,24)(H3,22,27,28,33)/t6-,7-,10-,11-,12-,13-,18-,19-/m1/s1 | | Synonyms: | 2',3' cGAMP | | Definition date: | 2013-05-24 | | Last modified: | 2020-05-26 | | Release date: | 2013-06-12 | | Identifier: | 2-amino-9-[(2R,5R,7R,8R,10S,12aR,14R,15R,15aS,16R)-14-(6-amino-9H-purin-9-yl)-2,10,15,16-tetrahydroxy-2,10-dioxidooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecin-7-yl]-3,9-dihydro-6H-purin-6-one |
|
 | | 1WE | | Name: | (2S)-1-phenylpropan-2-amine | | Formula: | C9 H13 N | | SMILES: | NC(Cc1ccccc1)C | | InChi: | InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1 | | Synonyms: | Dextroamphetamine | | Definition date: | 2013-07-05 | | Last modified: | 2020-05-26 | | Release date: | 2013-12-11 | | Identifier: | (2S)-1-phenylpropan-2-amine |
|
 | | 0XW | | Name: | (2S,4R)-4-hydroxy-1,1-dimethylpyrrolidinium-2-carboxylate | | Formula: | C7 H13 N O3 | | SMILES: | O=C([O-])C1[N+](C)(C)CC(O)C1 | | InChi: | InChI=1S/C7H13NO3/c1-8(2)4-5(9)3-6(8)7(10)11/h5-6,9H,3-4H2,1-2H3/t5-,6+/m1/s1 | | Synonyms: | Betonicine | | Definition date: | 2012-09-17 | | Last modified: | 2020-05-26 | | Release date: | 2012-10-05 | | Identifier: | (2S,4R)-4-hydroxy-1,1-dimethylpyrrolidinium-2-carboxylate |
|
 | | 0ZO | | Name: | N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]-L-prolinamide | | Formula: | C25 H35 Cl N4 O7 | | SMILES: | O=C(NC(Cc1ccccc1)C(O)CCl)C2N(C(=O)C(NC(=O)C(NC(=O)CCC(=O)O)C)C)CCC2 | | InChi: | InChI=1S/C25H35ClN4O7/c1-15(27-21(32)10-11-22(33)34)23(35)28-16(2)25(37)30-12-6-9-19(30)24(36)29-18(20(31)14-26)13-17-7-4-3-5-8-17/h3-5,7-8,15-16,18-20,31H,6,9-14H2,1-2H3,(H,27,32)(H,28,35)(H,29,36)(H,33,34)/t15-,16-,18-,19-,20+/m0/s1 | | Synonyms: | AAPF-chloromethylketone | | Definition date: | 2009-01-13 | | Last modified: | 2020-05-26 | | Identifier: | N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]-L-prolinamide |
|
 | | 89F | | Name: | 1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine | | Formula: | C20 H24 N2 S2 | | SMILES: | CSc1ccc2Sc3ccccc3C[CH](N4CCN(C)CC4)c2c1 | | InChi: | InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3/t18-/m0/s1 | | Synonyms: | Methiothepin | | Definition date: | 2017-05-19 | | Last modified: | 2020-05-26 | | Release date: | 2018-02-07 | | Identifier: | 1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine |
|
 | | 8CB | | Name: | (1'R,2'R)-4,5'-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol | | Formula: | C17 H22 O2 | | SMILES: | Oc2c(C1C(CCC(=C1)C)/C(C)=C)c(O)cc(c2)C | | InChi: | InChI=1S/C17H22O2/c1-10(2)13-6-5-11(3)7-14(13)17-15(18)8-12(4)9-16(17)19/h7-9,13-14,18-19H,1,5-6H2,2-4H3/t13-,14+/m0/s1 | | Synonyms: | cannabidiorcin | | Definition date: | 2018-07-26 | | Last modified: | 2020-05-26 | | Release date: | 2019-02-13 | | Identifier: | (1'R,2'R)-4,5'-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol |
|
 | | AB1 | | Name: | N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE | | Formula: | C37 H48 N4 O5 | | SMILES: | O=C(NC(Cc1ccccc1)C(O)CC(NC(=O)C(N2C(=O)NCCC2)C(C)C)Cc3ccccc3)COc4c(cccc4C)C | | InChi: | InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 | | Synonyms: | ABT-378 | | Definition date: | 2002-09-24 | | Last modified: | 2020-05-26 | | Identifier: | (2S)-N-[(1S,3S,4S)-1-benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide |
|
 | | AIN | | Name: | 2-(ACETYLOXY)BENZOIC ACID | | Formula: | C9 H8 O4 | | SMILES: | O=C(Oc1ccccc1C(=O)O)C | | InChi: | InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) | | Synonyms: | ACETYLSALICYLIC ACID | | Definition date: | 2004-04-08 | | Last modified: | 2020-05-26 | | Identifier: | 2-(acetyloxy)benzoic acid |
|
 | | 2PM | | Name: | N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE | | Formula: | C17 H21 N O | | SMILES: | O(CCN(C)C)C(c1ccccc1)c2ccccc2 | | InChi: | InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 | | Synonyms: | DIPHENHYDRAMINE | | Definition date: | 2005-08-30 | | Last modified: | 2020-05-26 | | Identifier: | 2-(diphenylmethoxy)-N,N-dimethylethanamine |
|
 | | 2Y5 | | Name: | (2R)-1-{[(R)-hydroxy{[(1R,2R,3R,4R,5S,6R)-2,3,5,6-tetrahydroxy-4-(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | | Formula: | C47 H84 O16 P2 | | SMILES: | O=C(OCC(OC(=O)CCCC=C/CC=C/CC=C/CC=C/CCCCC)COP(=O)(O)OC1C(O)C(O)C(OP(=O)(O)O)C(O)C1O)CCCCCCCCCCCCCCCCC | | InChi: | InChI=1S/C47H84O16P2/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(49)61-39(37-59-40(48)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2)38-60-65(57,58)63-47-44(52)42(50)46(43(51)45(47)53)62-64(54,55)56/h11,13,17,19,22,24,28,30,39,42-47,50-53H,3-10,12,14-16,18,20-21,23,25-27,29,31-38H2,1-2H3,(H,57,58)(H2,54,55,56)/b13-11-,19-17-,24-22-,30-28-/t39-,42-,43+,44-,45-,46+,47+/m1/s1 | | Synonyms: | Phosphatidylinositol-4-phosphate | | Definition date: | 2014-05-12 | | Last modified: | 2020-05-26 | | Release date: | 2015-07-29 | | Identifier: | (2R)-1-{[(R)-hydroxy{[(1R,2R,3R,4R,5S,6R)-2,3,5,6-tetrahydroxy-4-(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate |
|
 | | BMO | | Name: | N-ACRIDIN-9-YL-N'-[3-(ACRIDIN-9-YLAMINO)PROPYL]PROPANE-1,3-DIAMINE | | Formula: | C32 H31 N5 | | SMILES: | n2c1c(cccc1)c(c3c2cccc3)NCCCNCCCNc4c6c(nc5c4cccc5)cccc6 | | InChi: | InChI=1S/C32H31N5/c1-5-15-27-23(11-1)31(24-12-2-6-16-28(24)36-27)34-21-9-19-33-20-10-22-35-32-25-13-3-7-17-29(25)37-30-18-8-4-14-26(30)32/h1-8,11-18,33H,9-10,19-22H2,(H,34,36)(H,35,37) | | Synonyms: | 1,3-PROPANEDIAMINE | | Definition date: | 2006-04-25 | | Last modified: | 2020-05-26 | | Identifier: | N-acridin-9-yl-N'-[3-(acridin-9-ylamino)propyl]propane-1,3-diamine |
|
 | | 69Q | | Name: | 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol | | Formula: | C19 H17 F6 N7 O | | SMILES: | c3(cccc(c1nc(NCC(O)(C)C)nc(n1)Nc2cc(ncc2)C(F)(F)F)n3)C(F)(F)F | | InChi: | InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32) | | Synonyms: | Enasidenib | | Definition date: | 2016-02-22 | | Last modified: | 2020-05-26 | | Release date: | 2017-03-08 | | Identifier: | 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol |
|
 | | 989 | | Name: | 2-{[4-(2-ACETYLAMINO-2-PENTYLCARBAMOYL-ETHYL)-NAPHTHALEN-1-YL]-OXALYL-AMINO}-BENZOIC ACID | | Formula: | C29 H31 N3 O7 | | SMILES: | O=C(N(c2c1ccccc1c(cc2)CC(C(=O)NCCCCC)NC(=O)C)c3ccccc3C(=O)O)C(=O)O | | InChi: | InChI=1S/C29H31N3O7/c1-3-4-9-16-30-26(34)23(31-18(2)33)17-19-14-15-25(21-11-6-5-10-20(19)21)32(27(35)29(38)39)24-13-8-7-12-22(24)28(36)37/h5-8,10-15,23H,3-4,9,16-17H2,1-2H3,(H,30,34)(H,31,33)(H,36,37)(H,38,39)/t23-/m0/s1 | | Synonyms: | COMPOUND 12 | | Definition date: | 2003-01-30 | | Last modified: | 2020-05-26 | | Identifier: | 2-[{4-[(2S)-2-(acetylamino)-3-oxo-3-(pentylamino)propyl]naphthalen-1-yl}(carboxycarbonyl)amino]benzoic acid |
|
 | | 9CS | | Name: | (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-[(3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSIDE | | Formula: | C18 H37 N5 O10 | | SMILES: | O(C2C(O)C(OC1OC(CN)C(O)C(O)C1N)C(N)CC2N)C3OC(C(O)C(N)C3O)CO | | InChi: | InChI=1S/C18H37N5O10/c19-2-6-11(26)12(27)9(23)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)8(22)10(25)7(3-24)31-18/h4-18,24-29H,1-3,19-23H2/t4-,5+,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1 | | Synonyms: | Kanamycin B | | Definition date: | 2007-07-13 | | Last modified: | 2020-05-26 | | Identifier: | (1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside |
|
 | | BUN | | Name: | (2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one | | Formula: | C15 H12 O5 | | SMILES: | O=C(c1ccc(O)cc1O)C=Cc2cc(O)c(O)cc2 | | InChi: | InChI=1S/C15H12O5/c16-10-3-4-11(14(19)8-10)12(17)5-1-9-2-6-13(18)15(20)7-9/h1-8,16,18-20H/b5-1+ | | Synonyms: | 2',3,4,4'-Tetrahydroxychalcone | | Definition date: | 2014-10-20 | | Last modified: | 2020-05-26 | | Release date: | 2015-10-21 | | Identifier: | (2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one |
|
 | | 5UF | | Name: | (3~{S})-3-oxidanyldecanoic acid | | Formula: | C10 H20 O3 | | SMILES: | CCCCCCC[CH](O)CC(O)=O | | InChi: | InChI=1S/C10H20O3/c1-2-3-4-5-6-7-9(11)8-10(12)13/h9,11H,2-8H2,1H3,(H,12,13)/t9-/m0/s1 | | Synonyms: | Myrmicacin | | Definition date: | 2015-12-02 | | Last modified: | 2020-05-26 | | Release date: | 2015-12-29 | | Identifier: | (3~{S})-3-oxidanyldecanoic acid |
|
 | | 08D | | Name: | Sulfamethoxazole | | Formula: | C10 H11 N3 O3 S | | SMILES: | O=S(=O)(Nc1noc(c1)C)c2ccc(N)cc2 | | InChi: | InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13) | | Synonyms: | 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide | | Definition date: | 2011-10-13 | | Last modified: | 2020-05-26 | | Identifier: | 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide |
|
 | | 4MK | | Name: | 5-chloro-N~2~-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-N~4~-[2-(propan-2-ylsulfonyl)phenyl]pyrimidine-2,4-diamine | | Formula: | C28 H36 Cl N5 O3 S | | SMILES: | O=S(=O)(c1ccccc1Nc2nc(ncc2Cl)Nc3cc(c(cc3OC(C)C)C4CCNCC4)C)C(C)C | | InChi: | InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34) | | Synonyms: | Ceritinib | | Definition date: | 2013-09-16 | | Last modified: | 2020-05-26 | | Release date: | 2014-04-09 | | Identifier: | 5-chloro-N~2~-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-N~4~-[2-(propan-2-ylsulfonyl)phenyl]pyrimidine-2,4-diamine |
|
 | | AM2 | | Name: | APRAMYCIN | | Formula: | C21 H41 N5 O11 | | SMILES: | O3C(OC1OC(CO)C(N)C(O)C1O)C(NC)C(O)C4OC(OC2C(N)CC(N)C(O)C2O)C(N)CC34 | | InChi: | InChI=1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1 | | Synonyms: | NEBRAMYCIN II | | Definition date: | 2005-02-17 | | Last modified: | 2020-05-26 | | Identifier: | (2R,3R,4S,5S,6S)-5-amino-2-{[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl]oxy}-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol (non-preferred name) |
|
 | | 4BW | | Name: | 2-amino-9-[(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one | | Formula: | C20 H24 N10 O13 P2 | | SMILES: | O=C7NC(=Nc1c7ncn1C6OC5COP(=O)(O)OC4C(OC(n2c3ncnc(N)c3nc2)C4O)COP(=O)(OC5C6O)O)N | | InChi: | InChI=1S/C20H24N10O13P2/c21-14-8-15(24-3-23-14)29(4-25-8)18-10(31)12-6(40-18)1-38-45(36,37)43-13-7(2-39-44(34,35)42-12)41-19(11(13)32)30-5-26-9-16(30)27-20(22)28-17(9)33/h3-7,10-13,18-19,31-32H,1-2H2,(H,34,35)(H,36,37)(H2,21,23,24)(H3,22,27,28,33)/t6-,7-,10-,11-,12-,13-,18-,19-/m1/s1 | | Synonyms: | 3',3' cGAMP | | Definition date: | 2015-02-25 | | Last modified: | 2020-05-26 | | Release date: | 2015-04-15 | | Identifier: | 2-amino-9-[(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one |
|
 | | 2JT | | Name: | 1,3-dihydroxypropan-2-yl octadecanoate | | Formula: | C21 H42 O4 | | SMILES: | O=C(OC(CO)CO)CCCCCCCCCCCCCCCCC | | InChi: | InChI=1S/C21H42O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-20(18-22)19-23/h20,22-23H,2-19H2,1H3 | | Synonyms: | 2-Stearoylglycerol | | Definition date: | 2013-11-08 | | Last modified: | 2020-05-26 | | Release date: | 2014-04-23 | | Identifier: | 1,3-dihydroxypropan-2-yl octadecanoate |
|
 | | 1J1 | | Name: | N~6~-[(2R)-3,4-dihydro-2H-pyrrol-2-ylcarbonyl]-L-lysine | | Formula: | C11 H19 N3 O3 | | SMILES: | O=C(NCCCCC(C(=O)O)N)C1N=CCC1 | | InChi: | InChI=1S/C11H19N3O3/c12-8(11(16)17)4-1-2-6-14-10(15)9-5-3-7-13-9/h7-9H,1-6,12H2,(H,14,15)(H,16,17)/t8-,9+/m0/s1 | | Synonyms: | pyrroline-carboxy-lysine | | Definition date: | 2013-02-11 | | Last modified: | 2020-05-26 | | Release date: | 2013-06-12 | | Identifier: | N~6~-[(2R)-3,4-dihydro-2H-pyrrol-2-ylcarbonyl]-L-lysine |
|
 | | 1C6 | | Name: | 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole | | Formula: | C17 H19 N3 O2 S | | SMILES: | n2c1ccc(OC)cc1nc2SCc3ncc(c(OC)c3C)C | | InChi: | InChI=1S/C17H19N3O2S/c1-10-8-18-15(11(2)16(10)22-4)9-23-17-19-13-6-5-12(21-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20) | | Synonyms: | omeprazole | | Definition date: | 2013-04-29 | | Last modified: | 2020-05-26 | | Release date: | 2013-07-10 | | Identifier: | 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole |
|
 | | 1F0 | | Name: | [(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl]{4-[3-(methylsulfonyl)propyl]piperazin-1-yl}methanone | | Formula: | C38 H48 Cl2 N4 O4 S | | SMILES: | O=C(N1CCN(CCCS(=O)(=O)C)CC1)N4C(=NC(c2ccc(Cl)cc2)(C4(c3ccc(Cl)cc3)C)C)c5ccc(cc5OCC)C(C)(C)C | | InChi: | InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1 | | Synonyms: | RO5045337 | | Definition date: | 2013-01-10 | | Last modified: | 2020-05-26 | | Release date: | 2013-02-15 | | Identifier: | [(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl]{4-[3-(methylsulfonyl)propyl]piperazin-1-yl}methanone |
|
